Skip to main content
We gratefully acknowledge support from the Simons Foundation, member institutions, and all contributors. Donate
arXiv logo
Cornell University Logo

Quantitative Biology > Tissues and Organs

arXiv:1110.2727 (q-bio)
[Submitted on 12 Oct 2011]

Title:Prospects of using Antagonist Histamine H2-Receptor (Cimetidinum) as Adjuvant for Melanoma Biotherapy Treatment

Authors:I.V. Manina, N.M. Peretolchina, N.S. Saprikina, A.M. Kozlov, I.N. Mikhaylova, K.I. Jordanya A.Y. Barishnikov
View PDF
Abstract:Improvement of anti-tumor biotherapy effectiveness by modification of immune response with histamine H2 receptor Cimetidinum (CM) was studied using the experimental murine model of B16 F10 melanoma in vivo. It is shown that skin melanoma biotherapy by antitumor whole-cell GM-CSF-producing vaccine with the addition of CM (in dose of 25 mg/kg, daily for 5 days) increases preventive effects of vaccination. 33 % of mice did not have tumor growth within 60 days of observation. Average life span of animals exceeded those of the control group up to 68 %. Using CM-combined bio-chemotherapy doesn't improve therapeutic effect, however in the case of a monotherapeutic approach tendency for increased average life-time and decreased metastatic processes in mice with the developed tumors was noticed. Aquired data provides expediency to study the further application of CM as adjuvant for skin melanoma vaccinotherapy, and also the necessity to verify the immune status of an organism against the complex bio-chemotherapy.
Comments: 14 pages, 5 figures; ISSN 0236-297X. International Journal of Immunopathology, Allergology, Infectology. 2010, #4: P. 42-51
Subjects: Tissues and Organs (q-bio.TO); Cell Behavior (q-bio.CB)
Cite as: arXiv:1110.2727 [q-bio.TO]
  (or arXiv:1110.2727v1 [q-bio.TO] for this version)
  https://doi.org/10.48550/arXiv.1110.2727
Journal reference: International Journal of Immunopathology, Allergology, Infectology 2010, #4: P. 42-51

Submission history

From: Irina Manina [view email]
[v1] Wed, 12 Oct 2011 18:17:47 UTC (326 KB)
Full-text links:

Access Paper:

  • View PDF
license icon view license
Current browse context:
q-bio.TO
< prev   |   next >
new | recent | 2011-10
Change to browse by:
q-bio
q-bio.CB

References & Citations

export BibTeX citation

Bookmark

BibSonomy logo Reddit logo

Bibliographic and Citation Tools

Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)

Code, Data and Media Associated with this Article

alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)

Demos

Replicate (What is Replicate?)
Hugging Face Spaces (What is Spaces?)
TXYZ.AI (What is TXYZ.AI?)

Recommenders and Search Tools

Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)